Review





Similar Products

traf2  (ABclonal Biotechnology)
94
ABclonal Biotechnology traf2
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Traf2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/TRAF2+Rabbit+mAb/pmc13463070-555-15-16
Average 94 stars, based on 1 article reviews
traf2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
anti traf2  (ABclonal Biotechnology)
94
ABclonal Biotechnology anti traf2
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Anti Traf2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/%5BKO+Validated%5D+TRAF2+Rabbit+pAb/pmc13322541-144-11-13
Average 94 stars, based on 1 article reviews
anti traf2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
anti traf2  (Novus Biologicals)
94
Novus Biologicals anti traf2
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Anti Traf2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/TRAF-2+Antibody/pm42001092-145-45-46
Average 94 stars, based on 1 article reviews
anti traf2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
anti traf2 antibody  (Proteintech)
94
Proteintech anti traf2 antibody
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Anti Traf2 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/TRAF2+Antibody/pm41833106-70-25-28
Average 94 stars, based on 1 article reviews
anti traf2 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
traf2  (Proteintech)
94
Proteintech traf2
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Traf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/TRAF2+Antibody/bio_rxiv__64898__2026__03__15__711948-151-27-28
Average 94 stars, based on 1 article reviews
traf2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
anti phospho traf2  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc anti phospho traf2
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Anti Phospho Traf2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/TRAF2+Antibody/pm41737494-90-16-21
Average 95 stars, based on 1 article reviews
anti phospho traf2 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
antibodies against traf2  (Proteintech)
94
Proteintech antibodies against traf2
a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and <t>TRAF2</t> ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.
Antibodies Against Traf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+traf2/TRAF2+Antibody/pm41587214-309-0-3
Average 94 stars, based on 1 article reviews
antibodies against traf2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and TRAF2 ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Single cell spatial transcriptomics track the evolutionary hierarchy and microenvironment remodeling during breast carcinoma invasion

doi: 10.1038/s41467-026-74954-5

Figure Lengend Snippet: a Spatial distributions of oxidative phosphorylation (OXPH) and EMT signatures for Stereo-seq sample P13, P15, P16-1 and P28. The more the color tends towards yellow, the higher the score of the signature is. b Box plots comparing OXPH(up) and EMT(down) scores between DCIS and IBC cells. The tumor cells in this plots are derived from all 9 Stereo-seq samples. c, SPARC , TOP2A and ARAF spatial expression images of P35 (up) and P13 (down). Yellow and Red indicates higher expression compared to green and blue. d , f T47D breast cancer cells transfected with two specific siRNAs (targeting ARAF and TRAF2 ) or non-sense control siRNA. Proliferation assay shows reduced proliferation in siARAF-T47D and siTRAF2-T47D cell groups. The xCELLigence system was used for examining proliferation of these cells. e , g Transwell invasion assays show reduced invasion in siARAF-T47D and siTRAF2-T47D cell groups compared to the non-sense control siRNA group ( n = 4 biological replicates for each experiment. Data are representative of 3 independent experiments). Bar charts represent the quantified counts of invaded cells. Data are presented as mean ± SEM. Statistical analyses were performed using an unpaired two-sided Student’s t-test. Exact P -values are indicated directly above the bars. The detailed statistical results are as follows: siARAF-1 vs. siNC: P = 0.0003, t = 7.485, df = 6; siARAF-2 vs. siNC: P < 0.0001, t = 16.260, df = 6; siTRAF2-1 vs. siNC: P = 0.0101, t = 3.702, df = 6; siTRAF2-2 vs. siNC: P = 0.0088, t = 3.813, df = 6. h , i Bar plots showing the enriched pathways using IBC up-regulated DEGs in Stereo-seq sample P13( h ) and P35( i ). j Pie chart showing cell types and their proportions around IBC cells in Stereo-seq sample P35 (left) and P13 (right). Cells that are within a 15 μm radius of a IBC cell are included in the statistics. k H&E images of sample P35 (left) and P13 (right), with their selected IBC regions (middle). Source data are provided as a Source Data file.

Article Snippet: The primary antibodies used in this study were as follows: ARAF (Abclonal, Cat# A8687, 1:1000), TRAF2 (Abclonal, Cat# A19129, 1:50000), β-Actin (CST, Cat# 3700S, 1:1000), and GAPDH (Proteintech, Cat# 60004-1-Ig, 1:10000).

Techniques: Phospho-proteomics, Derivative Assay, Expressing, Transfection, Control, Proliferation Assay